Shares of vaccine makers BioNTech $BNTX and Moderna fell today ahead of a key CDC meeting to discuss booster vaccines..
Playoff
This meeting is the next step towards booster Covid vaccines for all recipients of messenger RNA injections from Pfizer vaccine manufacturers., BioNTech and Moderna. Medical experts will weigh the merits and risks of the White House plan, announced earlier this month.
- fell on
In its first iteration, the White House stated, what booster injections will offer, starting eight months after the second dose. But, according to CNBC, President Joe Biden discussed the possibility of boosters for five months. The U.S. would follow Israel's example.
"We are considering your advice, that you gave, so that we start earlier", – Biden said during a meeting with Israeli Prime Minister Naftali Bennett on Friday.. "It should take only five months., and it's being discussed.". Nevertheless, shares of vaccine makers fell on Friday.
Companies, vaccine-producing, receive billions of dollars in profitsCompany, vaccine-producing, receive billions of dollars in profits
The next step is the cdc Advisory Committee's decision on immunization practices.. The Committee meets today. Medical experts will make a formal recommendation that, Should the U.S. Start Injecting Booster Shots. Shares fell ahead of this meeting.
Emergency revaccination
Biden administration hopes to begin revaccination 20 September. White House press secretary Jen Psaki confirmed, what an eight month schedule remains valid. Officials from the CDC and the Food and Drug Administration will have to sign permission to launch accelerators in five months..
Rally Slows Down, Despite the Spread of the Delta Strain Amid All This, vaccine stock rally is now in limbo.
The plan of mass vaccination in the United States slowed down, despite the spread of the delta strain, when 52,3% all people in the U.S. were fully vaccinated. And medical experts don't all agree., that booster shots will help end the pandemic.
Moderna shares peaked in $497,49 6 august. By this point, the stock had more than quadrupled in 2021 year. But recently, stocks have fallen..
The same way, BioNTech shares peaked in $464 10 August after, how almost six times the closing price was 2020 year. But now the stock is close to 23% from this maximum.
